Kinarus Therapeutics (SIX:KNRS) None
Kinarus Therapeutics (SIX:KNRS) is a biopharmaceutical company that focuses on developing unique drugs for stress-related inflammatory conditions using cross-disease area target assessment.
Estimated Revenue:
CHF 20 million